emodin has been researched along with transforming growth factor beta in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (45.00) | 29.6817 |
2010's | 6 (30.00) | 24.3611 |
2020's | 5 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chan, TM; Lai, KN; Li, LS; Liu, ZH; Yung, S | 1 |
Gong, Z; Lou, K; Tu, S; Xu, J; Yuan, Y; Zhai, Z | 1 |
Gong, ZH; Lou, KX; Yuan, YZ | 1 |
Chan, TM; Leung, JK; Li, LS; Liu, ZH; Tsang, RC; Yung, S | 1 |
Bi, CS; Li, DG; Liu, B; Zhan, YT | 1 |
Gu, L; Wan, M; Wan, Y | 1 |
Fang, J; Liang, SW; Liu, JX; Lu, JS; Wang, D; Zhang, WY | 1 |
Dai, JF; Gui, M; Rui, YC; Sun, P; Wang, SF; Xiao, ZY; Zhang, JP; Zhang, YF | 1 |
Cai, JT; Du, Q; Gao, ZQ; Qian, KD; Wang, CH; Xie, CG; Ye, B | 1 |
Karunagaran, D; Thacker, PC | 1 |
Chen, H; Chen, L; Chen, MY; Guo, JQ; Hu, P; Ji, X; Lin, SZ; Lu, D; Tong, HF; Wang, ZH; Xu, HT; Xu, JB | 1 |
Qu, Y; Tao, Y | 1 |
Ho, CT; Hsu, HC; Hung, CM; Lin, YC; Liu, LC; Wang, HY; Way, TD | 1 |
Geng, Q; Liu, X; Qi, H; Shi, X; Wang, S; Wei, Q; Wen, S; Zhu, Q | 1 |
Dong, M; Niu, C; Wang, X; Zhang, X | 1 |
Bae, JS; Lee, IC | 1 |
Cheng, Y; Deng, C; Hu, H; Li, W; Liu, C; Liu, Y; Qian, J; Qin, S; Wang, J; Xia, Z; Yang, S | 1 |
Chen, HL; Huang, Y; Lu, SF; Lu, Y; Wu, L; Xing, ML; Yang, FR; Yang, QW; Zhang, YT | 1 |
Chen, X; Shen, G; Yin, J; Zhao, X | 1 |
Chen, C; Guan, S; Hu, Q; Hu, T; Jin, X; Lin, Z; Liu, W; Quan, S; Shen, J; Wang, J; Wu, X; Zhuang, X | 1 |
1 review(s) available for emodin and transforming growth factor beta
Article | Year |
---|---|
[Advances in the study on molecular mechanism of diabetic nephropathy treated with Rheum officinale].
Topics: Animals; Anthraquinones; Cytokines; Diabetic Nephropathies; Drugs, Chinese Herbal; Emodin; Humans; Interleukin-6; Plants, Medicinal; Rheum; Superoxide Dismutase; Thromboxane B2; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2003 |
19 other study(ies) available for emodin and transforming growth factor beta
Article | Year |
---|---|
Emodin ameliorates glucose-induced morphologic abnormalities and synthesis of transforming growth factor beta1 and fibronectin by human peritoneal mesothelial cells.
Topics: Blotting, Western; Cells, Cultured; Dose-Response Relationship, Drug; Emodin; Enzyme-Linked Immunosorbent Assay; Epithelium; Fibronectins; Gene Expression; Glucose; Humans; Mannitol; Peritoneal Dialysis; Peritoneum; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |
Mechanisms of Chinese herb emodin and somatostatin analogs on pancreatic regeneration in acute pancreatitis in rats.
Topics: Acute Disease; Amylases; Animals; DNA; Drugs, Chinese Herbal; Emodin; Enzyme Inhibitors; Epidermal Growth Factor; Gene Expression Regulation; Hormones; Male; Microscopy, Electron; Octreotide; Pancreas; Pancreatitis; Protein Biosynthesis; Proteins; Rats; Rats, Wistar; Regeneration; RNA, Messenger; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |
[Study on effect of emodin on TGF beta 1 expression in pancreatic tissue of rats suffering from acute pancreatitis].
Topics: Acute Disease; Animals; DNA; Emodin; Male; Pancreas; Pancreatitis; Random Allocation; Rats; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta | 2001 |
Emodin ameliorates glucose-induced matrix synthesis in human peritoneal mesothelial cells.
Topics: Biopsy; Carcinogens; Cell Division; Cells, Cultured; Collagen Type I; Cyclic AMP Response Element-Binding Protein; Emodin; Enzyme Inhibitors; Epithelial Cells; Epithelium; Extracellular Matrix Proteins; Fibronectins; Glucose; Humans; Peritoneum; Phosphorylation; Protein Kinase C; Protein Kinase C-alpha; Protein-Tyrosine Kinases; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
[Mechanism of emodin for anti-fibrosis of liver].
Topics: Animals; Cell Division; Emodin; Liver; Liver Cirrhosis, Experimental; Male; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
[Preventive effects of emodin on cerebral ischemia injury and expression of the inflammatory factors in rats with cerebral ischemia].
Topics: Animals; Brain; Brain Ischemia; Dose-Response Relationship, Drug; Emodin; Female; Interleukin-1beta; Male; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2005 |
Inhibitory effect of emodin on tissue inhibitor of metalloproteinases-1 (TIMP-1) expression in rat hepatic stellate cells.
Topics: Animals; Blotting, Western; Cells, Cultured; Electrophoretic Mobility Shift Assay; Emodin; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Humans; Liver; Mice; Phosphorylation; Rats; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1; Transcriptional Activation; Transforming Growth Factor beta | 2007 |
[Effect of emodin on pancreatic fibrosis: experiment with rats].
Topics: Animals; Blotting, Western; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Emodin; Fibrosis; Hyaluronic Acid; Laminin; Male; Pancreas; Pancreatic Diseases; Phytotherapy; Radioimmunoassay; Random Allocation; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Trinitrobenzenesulfonic Acid | 2006 |
Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells.
Topics: Antineoplastic Agents, Phytogenic; beta Catenin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Collagen; Curcumin; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Drug Combinations; Drug Synergism; Emodin; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Laminin; NIMA-Interacting Peptidylprolyl Isomerase; Peptidylprolyl Isomerase; Protein Serine-Threonine Kinases; Proteoglycans; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Signal Transduction; Smad3 Protein; Smad4 Protein; Snail Family Transcription Factors; Transcription Factors; Transforming Growth Factor beta; Wnt Proteins | 2015 |
Emodin inhibits angiogenesis in pancreatic cancer by regulating the transforming growth factor-β/drosophila mothers against decapentaplegic pathway and angiogenesis-associated microRNAs.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Biomarkers; Cell Line, Tumor; Disease Models, Animal; Emodin; Female; Gene Expression; Heterografts; Humans; Mice; MicroRNAs; Neovascularization, Pathologic; Pancreatic Neoplasms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; RNA, Messenger; Smad4 Protein; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Burden | 2015 |
[Influence of Emodin Gel on the Fibroblasts of Hypertrophic Scars in Rabbit Ear Model].
Topics: Animals; Cicatrix, Hypertrophic; Cytoplasm; Disease Models, Animal; Emodin; Fibroblasts; Gels; Hardness; Interleukin-1; Microscopy, Electron, Transmission; Rabbits; Transforming Growth Factor beta | 2015 |
Stromal Fibroblasts from the Interface Zone of Triple Negative Breast Carcinomas Induced Epithelial-Mesenchymal Transition and its Inhibition by Emodin.
Topics: Cancer-Associated Fibroblasts; Cell Line, Tumor; Emodin; Epithelial-Mesenchymal Transition; Female; Fibroblasts; Humans; Phenotype; Transforming Growth Factor beta; Triple Negative Breast Neoplasms | 2017 |
Physcion 8‑O‑β‑glucopyranoside extracted from Polygonum cuspidatum exhibits anti‑proliferative and anti‑inflammatory effects on MH7A rheumatoid arthritis‑derived fibroblast‑like synoviocytes through the TGF‑β/MAPK pathway.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Line; Cell Proliferation; Emodin; Fallopia japonica; Female; Glucosides; Interleukins; Male; MAP Kinase Signaling System; Rats; Signal Transduction; Synoviocytes; Transforming Growth Factor beta | 2018 |
Emodin suppresses activation of hepatic stellate cells through p38 mitogen-activated protein kinase and Smad signaling pathways in vitro.
Topics: Animals; Cell Proliferation; Cells, Cultured; Collagen Type I; Emodin; Fibronectins; HEK293 Cells; Hepatic Stellate Cells; Humans; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2018 |
Inhibitory effects of aloin on TGFBIp-mediated septic responses.
Topics: Animals; Emodin; Extracellular Matrix Proteins; Human Umbilical Vein Endothelial Cells; Mice; Mice, Inbred C57BL; Molecular Structure; Transforming Growth Factor beta | 2021 |
Emodin alleviates hypertrophic scar formation by suppressing macrophage polarization and inhibiting the Notch and TGF-β pathways in macrophages.
Topics: Animals; Cicatrix, Hypertrophic; Emodin; Macrophages; Rats; Signal Transduction; Transforming Growth Factor beta | 2021 |
Multi-material basis and multi-mechanisms of the Dahuang Zhechong pill for regulating Treg/Th1 balance in hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Drugs, Chinese Herbal; Emodin; Glutamine; Liver Neoplasms; Mice; T-Lymphocytes, Regulatory; Tandem Mass Spectrometry; Transforming Growth Factor beta; Tumor Microenvironment | 2022 |
Emodin suppresses hepatocellular carcinoma growth by regulating macrophage polarization via microRNA-26a/transforming growth factor beta 1/protein kinase B.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Emodin; Humans; Liver Neoplasms; Macrophages; MicroRNAs; Proto-Oncogene Proteins c-akt; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2022 |
Emodin accelerates diabetic wound healing by promoting anti-inflammatory macrophage polarization.
Topics: Animals; Anti-Inflammatory Agents; Diabetes Mellitus, Experimental; Emodin; Macrophages; Mice; NF-kappa B; Transforming Growth Factor beta; Wound Healing | 2022 |